Skip to main content
. 2023 Feb 23;9(1):e002789. doi: 10.1136/rmdopen-2022-002789

Figure 1.

Figure 1

Mean change from baseline to week 100 in total PsA-modified vdH-S score for patients who achieved clinical response at week 52 (A) or week 100 (B). ACR 20/50/70, ≥20%/50%/70% improvement in American College of Rheumatology criteria; DAPSA, Disease Activity in Psoriatic Arthritis; HAQ-DI, Health Assessment Questionnaire-Disability Index; LDA, low disease activity; MDA, minimal disease activity; PASDAS, Psoriatic Arthritis Disease Activity Score; PsA-modified vdH-S score, van der Heijde-Sharp score modified for psoriatic arthritis; Q4W, every 4 weeks; Q8W, every 8 weeks.